Literature DB >> 1764758

[Antivenom serotherapy: its applications, its limitations, its future].

J P Chippaux1, M Goyffon.   

Abstract

A hundred years after its discovery, authors review the antivenom therapy. Antivenom manufacture is described and antivenom therapy methods are presented. Indication of antivenom should be reserved to those who are really envenomed. Delay from the bite should not discredit antivenom therapy. Quantity of antivenom should depend on snake species, clinical features and evolution after treatment. Intravenous injections of antivenom should be strongly recommended as the most efficient. The future of antivenom therapy is emphasized.

Mesh:

Substances:

Year:  1991        PMID: 1764758

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  3 in total

1.  Why there are no effective herbal antidotes against snake venom available in India?

Authors:  Antony Gomes; Sourav Ghosh; Aparna Gomes
Journal:  Indian J Med Res       Date:  2020-06       Impact factor: 2.375

2.  Development and Characterization of Anti-Naja ashei Three-Finger Toxins (3FTxs)-Specific Monoclonal Antibodies and Evaluation of Their In Vitro Inhibition Activity.

Authors:  Ernest Z Manson; Mutinda C Kyama; Josephine Kimani; Aleksandra Bocian; Konrad K Hus; Vladimír Petrilla; Jaroslav Legáth; James H Kimotho
Journal:  Toxins (Basel)       Date:  2022-04-16       Impact factor: 5.075

3.  Cobra venom neutralization by gold nano particle-2-hydroxy-4-methoxy benzoic acid.

Authors:  Kalyani Saha; Sourav Ghosh; Aparna Gomes; Subir Chandra Dasgupta; Antony Gomes
Journal:  Indian J Pharmacol       Date:  2021 Jan-Feb       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.